89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,406,244 | -85.2% | 91,078 | -81.9% | 0.05% | -87.8% |
| Q2 2023 | $9,533,745 | -65.3% | 503,100 | -72.1% | 0.44% | -60.9% |
| Q1 2023 | $27,481,012 | -43.9% | 1,804,400 | -53.1% | 1.13% | -45.1% |
| Q4 2022 | $49,010,500 | +221.1% | 3,850,000 | +46.1% | 2.06% | +194.4% |
| Q3 2022 | $15,262,000 | – | 2,636,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |